Chess Robert's Form 4 filing
Twist Bioscience Corp (TWST) · filed Jul 14, 2021
- Accession no.
- 0001214659-21-007500
- Filed
- Jul 14, 2021
- Trade date
- Jul 12, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $503.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chess RobertCIK 0001227886 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | Common Stock | SSaleDisposed | −610 | $124.37F2 | −$75,865.7 | 66,404 | Direct | |
| Jul 12, 2021 | Common Stock | SSaleDisposed | −2,495 | $125.45F3 | −$312,997.75 | 63,909 | Direct | |
| Jul 12, 2021 | Common Stock | SSaleDisposed | −155 | $126.00F4 | −$19,530 | 63,754 | Direct | |
| Jul 12, 2021 | Common Stock | SSaleDisposed | −200 | $127.14F5 | −$25,428 | 63,554 | Direct | |
| Jul 12, 2021 | Common Stock | SSaleDisposed | −300 | $128.38F6 | −$38,514 | 63,254 | Direct | |
| Jul 12, 2021 | Common Stock | SSaleDisposed | −240 | $130.46F7 | −$31,310.4 | 63,014 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sales price per share. The shares sold at prices ranging from $123.71 to $124.63 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sales price per share. The shares sold at prices ranging from $124.98 to $125.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sales price per share. The shares sold at prices ranging from $125.98 to $126.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sales price per share. The shares sold at prices ranging from $127.08 to $127.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sales price per share. The shares sold at prices ranging from $128.15 to $128.66 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average sales price per share. The shares sold at prices ranging from $130.20 to $130.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.